Increased Level of Basophil CD203c Expression Predicts Severe Chronic Urticaria

다국어 초록 (Multilingual Abstract)

Increased FcεR1α expression with upregulated CD203c expression on peripheral basophils is seen in patients with chronic urticaria (CU). However, there has been no published report on the association between CD203c expression level and clinical disease activity in CU patients. To investigate whether the increase of basophil activation is associated with the disease activity of CU, we measured basophil CD203c expression using a tricolor flow cytometric method in 82 CU patients and 21 normal controls. The relationship between the percentage of CD203c-expressing basophils and clinical parameters was analyzed. The mean basophil CD203c expression was significantly higher in CU patients than in healthy controls (57.5% vs 11.6%, P<0.001). The basophil CD203c expression in severe CU patients was significantly higher than in non-severe CU (66.5%±23.3% vs 54.0%±23.3%, P=0.033). Multiple logistic regression analysis indicated that both ≥72% basophil CD203c expression and urticaria activity score (UAS)≥13 were significant predictors of severe CU (P=0.005 and P=0.032, respectively). These findings suggest that the quantification of basophil activation with CD203c at baseline may be used as a potential predictor of severe CU requiring another treatment option beyond antihistamines.

참고문헌 (Reference)

1 Kaplan AP, "Treatment of chronic spontaneous urticaria" 4 : 326-331, 2012

2 Morgan M, "Therapeutic alternatives for chronic urticaria: an evidence-based review, part 1" 100 : 403-411, 2008

3 Falcone FH, "The role of basophils in the pathogenesis of allergic disease" 41 : 939-947, 2011

4 Bühring HJ, "The basophil-specific ectoenzyme E-NPP3(CD203c)as a marker for cell activation and allergy diagnosis" 133 : 317-329, 2004

5 Tedeschi A, "Serum interleukin-18 in patients with chronic ordinary urticaria: association with disease activity" 32 : 568-570, 2007

6 Grattan CE, "Randomized double-blind study of cyclosporin in chronic ‘idiopathic’ urticaria" 143 : 365-372, 2000

7 Kasperska-Zajac A, "Plasma IL-6 concentration correlates with clinical disease activity and serum C-reactive protein concentration in chronic urticaria patients" 41 : 1386-1391, 2011

8 Boumiza R, "Marked improvement of the basophil activation test by detecting CD203c instead of CD63" 33 : 259-265, 2003

9 Gentinetta T, "Individual IL-3 priming is crucial for consistent in vitro activation of donor basophils in patients with chronic urticaria" 128 : 1227-34.e5-, 2011

10 Kessel A, "Increased plasma levels of matrix metalloproteinase-9 are associated with the severity of chronic urticaria" 35 : 221-225, 2005

11 Schroeder JT, "Human basophils secrete IL-3: evidence of autocrine priming for phenotypic and functional responses in allergic disease" 182 : 2432-2438, 2009

12 Saini SS, "How IgE upregulates the allergic response" 14 : 694-697, 2002

13 Vasagar K, "Evidence of in vivo basophil activation in chronic idiopathic urticaria" 36 : 770-776, 2006

14 남영희, "Effects of Omalizumab Treatment in Patients With Refractory Chronic Urticaria" 대한천식알레르기학회 4 (4): 357-361, 2012

15 Zuberbier T, "EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria" 64 : 1417-1426, 2009

16 Zuberbier T, "EAACI/GA(2)LEN/EDF/WAO guideline : management of urticaria" 64 : 1427-1443, 2009

17 Triwongwaranat D, "Correlation between plasma D-dimer levels and the severity of patients with chronic urticaria" 3 : 100-105, 2013

18 Ye YM, "Clinical evaluation of the computerized chronic urticaria-specific quality of life questionnaire in Korean patients with chronic urticaria" 37 : 722-728, 2012

19 Yasnowsky KM, "Chronic urticaria sera increase basophil CD203c expression" 117 : 1430-1434, 2006

20 Chinuki Y, "CD203c expression-based basophil activation test for diagnosis of wheat-dependent exercise-induced anaphylaxis" 129 : 1404-1406, 2012

21 Grattan CE, "Blood basophil numbers in chronic ordinary urticaria and healthy controls: diurnal variation, influence of loratadine and prednisolone and relationship to disease activity" 33 : 337-341, 2003

22 Ito Y, "Basophil recruitment and activation in inflammatory skin diseases" 66 : 1107-1113, 2011

23 Eckman JA, "Basophil phenotypes in chronic idiopathic urticaria in relation to disease activity and autoantibodies" 128 : 1956-1963, 2008

24 Chirumbolo S., "Basophil activation test in allergy: time for an update?" 158 : 99-114, 2012

25 Gernez Y, "Basophil CD203c levels are increased at baseline and can be used to monitor omalizumab treatment in subjects with nut allergy" 154 : 318-327, 2011

26 Asero R, "Assessment of histamine-releasing activity of sera from patients with chronic urticaria showing positive autologous skin test on human basophils and mast cells" 34 : 1111-1114, 2004

27 Lourenço FD, "Activated status of basophils in chronic urticaria leads to interleukin-3 hyper-responsiveness and enhancement of histamine release induced by anti-IgE stimulus" 158 : 979-986, 2008